Diagnostic imaging in Parkinson's disease

Area of Science:

• Neurology
• Radiology
• Medical Imaging

Background:

• Differentiating Parkinson's disease (PD) from other parkinsonian syndromes (PS) is crucial for accurate diagnosis and treatment.
• Standard brain MRI is primarily used to exclude other neurological conditions presenting with parkinsonian symptoms.

Purpose of the Study:

• To review the utility of various neuroimaging techniques in differentiating PD from other PS.
• To highlight emerging MRI techniques and their diagnostic value.

Main Methods:

• Review of current literature on neuroimaging in PD and PS.
• Discussion of techniques including functional MRI, neuromelanin imaging, MIBG cardiac scintigraphy, dopamine transporter imaging, brain perfusion imaging, and transcranial sonography (TCS).

Main Results:

• Functional MRI and neuromelanin imaging are emerging tools for PD diagnosis.
• MIBG cardiac scintigraphy is sensitive for differentiating PD from other PS.
• Dopamine transporter imaging detects early neurodegeneration but struggles to differentiate PD from other neurodegenerative PS.
• TCS of the substantia nigra is useful but may have limitations in specific populations.

Conclusions:

• Neuroimaging plays a vital role in the differential diagnosis of PD.
• A combination of imaging modalities may be necessary for definitive diagnosis.
• Further research is needed to overcome limitations of current techniques, especially for TCS in certain demographics.